Allertin Intro Assigned to GGC

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

LOS ANGELES Gardner Geary Coll has been chosen to help launch pharmaceutical company BioGentec’s flagship allergy product, Allertin.

The San Francisco shop won the account after a review that included Eicoff Direct-Health in Chicago, the client said.

Annual billings have not been determined. BioGentec is expected to spend $4-5 million for a test-market launch in July.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in